06 Sep 2019

EUCAST recruits PKPD experts Shampa Das and Joseph Meletiadis

In an open process EUCAST has recruited two PKPD experts, Shampa Das (UK) and Joseph Meletiadis (Greece and NL) and thereby increased its competence in the field. 

Recognising the pivotal importance of pharmacokinetics and pharmacodynamics (PK/PD) in the process of setting clinical breakpoints, EUCAST recruited two PK/PD experts during the summer of 2019. Both will be members of the Steering Committee.


Dr Shampa Das is a Senior Lecturer at the Centre for Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, UK. She has previously been employed as a Director of Clinical Pharmacology at the Antibiotics Unit, AstraZeneca. She has vast experience with drug development, preclinical PK/PD and clinical support to aid optimal dose selection, as well as extensive experience with the regulatory process.


Dr Joseph Meletiadis is an Associate Professor of Microbiology at the University of Athens, and Head of the Mycology Unit in Attikon General Hospital, Athens, Greece. He is also a research scientist in the Erasmus Medical Center, Rotterdam, The Netherlands. Dr Meletiadis is also the clinical data coordinator of the EUCAST Subcommittee for antifungal susceptibility testing (AFST) and a member of the executive committee of the ESCMID Study Group on PK/PD of anti-infectives. Joseph has extensive experience with in vitro and in vivo PK-PD modelling and MIC-testing in relation to the setting of clinical breakpoints.


We welcome Shampa and Joseph to the EUCAST Steering Committee!